default author photo

Naga Prasad V

Aurobindo Pharma Limited

Hyderabad

India

  • Aurobindo Pharma Limited

SCHOLARLY PAPERS

1

DOWNLOADS

294

TOTAL CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

Efficacy and Safety of Molnupiravir for the Treatment of Non-Hospitalized Adults With Mild COVID-19: A Randomized, Open-Label, Parallel-Group Phase 3 Trial

Number of pages: 18 Posted: 24 Feb 2022
Sudhakar Koudinya Tippabhotla, Dr. Subhra Lahiri, Rama Raju D, Chandrashekhar Kandi and Naga Prasad V
Aurobindo Pharma Limited - APL Research Centre-I, AXIS Clinicals Limited, Aurobindo Pharma Limited - APL Research Centre-I, Aurobindo Pharma Limited - APL Research Centre-II and Aurobindo Pharma Limited
Downloads 294 (258,599)

Abstract:

Loading...

molnupiravir, efficacy, safety, COVID-19, mild, non-hospitalized, randomized